Literature DB >> 32277963

Super-spreading events and contribution to transmission of MERS, SARS, and SARS-CoV-2 (COVID-19).

J A Al-Tawfiq1, A J Rodriguez-Morales2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32277963      PMCID: PMC7194732          DOI: 10.1016/j.jhin.2020.04.002

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


× No keyword cloud information.

Introduction

There is no clear definition for the term ‘super-spreader’ or ‘super-spreading event’. The World Health Organization refers to a super-spreader as a patient (or an event) that may transmit infection to a larger number of individuals than is usual by one individual (or event). In the severe acute respiratory syndrome (SARS) situation, a super-spreading event was defined as the transmission of SARS to at ≥8 contacts, and other authors defined this as individuals infecting an unusually large number of secondary cases [1,2]. A super-spreading event could merely be defined as an event in which one patient infects far more people than an average patient does, which is estimated by the basic reproduction number (R0).

Super-spreading events during SARS, MERS, and COVID

A super-spreading event was recognized during the SARS outbreak when a flight attendant infected more than 100 patients in Singapore [3]. In the situation of Middle East respiratory syndrome coronavirus (MERS-CoV), one patient infected 82 individuals during his course of illness during an outbreak in South Korea [4]. This index case in the Republic of Korea resulted in 27 secondary cases; one of these cases infected an additional 24 tertiary cases, and a third patient caused 73 tertiary cases [5]. In the current coronavirus disease (COVID-19) pandemic, the third British man contracted SARS-CoV-2 at a conference in Singapore and then travelled to France and stayed with a family in a ski chalet (Alpine resort). Five of his contacts tested positive [6]. In South Korea, 37 cases were linked to the religious sect, the Shincheonji Church of Jesus.

What explains a super-spreading event?

There are multiple explanations for the occurrence of super-spreading events, including immune suppression, increased disease severity and viral load, asymptomatic individuals, and extensive social interactions [7]. Individuals with immune suppression may shed virus at a higher level and for a longer duration and may have atypical presentation [8]. Patients with severe disease may have higher viral loads and thus are more likely to shed higher infectious doses. In one study of MERS-CoV, critically ill patients had a longer duration of transmission and shedding of the virus [9]. Another explanation is that super-spreading events may occur because individuals with no or mild symptoms may go unrecognized, and no measures are implemented. Such cases would then lead to widespread dissemination of the virus before recognition and application of infection control measures. The contribution of asymptomatic individuals to the spread of coronavirus is not well understood. Serologic testing in the case of SARS-CoV showed a positive rate of 13% in asymptomatic individuals compared with 82% in severe disease and 4% in those with mild symptoms [10]. One study indicated that an asymptomatic patient with COVID-19 transmitted the SARS-CoV-2 to another patient in Germany [11]. Another possibility is that super-spreading may be the result of increased interaction between the index case and other people, so an individual who has multiple and extensive social life is more likely to infect a greater number of individuals than the person who has limited social interaction. Thus, it is imperative to practice social distancing to flatten the curve during an epidemic. Children may be at higher rate of being asymptomatic and thus may shed the virus and cause infection in other people. However, previous studies of SARS and MERS did not reveal a high rate of childhood infection; one study of 1250 patients showed that paediatric cases constituted 3.3% (in those aged <10 years) and that serologic assay was positive in 0.1% of children compared to 0.7% overall [12]. Another possible contributing factor is variability in viral shedding. Super-spreading events have been linked to extensive and prolonged viral shedding, and situations with sub-optimal infection control [13]. Additional factors that might also contribute to a super-spreading event include prolonged duration of exposure, the practice of seeking care at multiple healthcare facilities, frequent inter-hospital transfer, and large numbers of contacts [14]. A higher viral load, more environmental contacts, and more interpersonal contacts, and a complex network of interactions made by individuals may also play further roles in super-spreading events. In conclusion, the occurrence of super-spreading events has contributed to the transmission of SARS, MERS-CoV, and SARS-CoV-2. There are multiple factors contributing to this event, including: immune suppression, increased disease severity and viral load, asymptomatic individuals, and extensive social interactions.

Conflict of interest statement

None declared.

Funding sources

None.
  14 in total

1.  An event-based model of superspreading in epidemics.

Authors:  Alex James; Jonathan W Pitchford; Michael J Plank
Journal:  Proc Biol Sci       Date:  2007-03-07       Impact factor: 5.349

2.  Preliminary case report on the SARS-CoV-2 cluster in the UK, France, and Spain

Authors:  Emma B Hodcroft
Journal:  Swiss Med Wkly       Date:  2020-02-27       Impact factor: 2.193

Review 3.  Middle East respiratory syndrome coronavirus in healthcare settings.

Authors:  Jaffar A Al-Tawfiq; Trish M Perl
Journal:  Curr Opin Infect Dis       Date:  2015-08       Impact factor: 4.915

4.  Role of disease-associated tolerance in infectious superspreaders.

Authors:  Smita Gopinath; Joshua S Lichtman; Donna M Bouley; Joshua E Elias; Denise M Monack
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-20       Impact factor: 11.205

5.  Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015.

Authors:  B J Cowling; M Park; V J Fang; P Wu; G M Leung; J T Wu
Journal:  Euro Surveill       Date:  2015-06-25

6.  Asymptomatic SARS coronavirus infection among healthcare workers, Singapore.

Authors:  Annelies Wilder-Smith; Monica D Teleman; Bee H Heng; Arul Earnest; Ai E Ling; Yee S Leo
Journal:  Emerg Infect Dis       Date:  2005-07       Impact factor: 6.883

7.  Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea, 2015.

Authors: 
Journal:  Osong Public Health Res Perspect       Date:  2015-09-05

8.  Association of Higher MERS-CoV Virus Load with Severe Disease and Death, Saudi Arabia, 2014.

Authors:  Daniel R Feikin; Basem Alraddadi; Mohammed Qutub; Omaima Shabouni; Aaron Curns; Ikwo K Oboho; Sara M Tomczyk; Bernard Wolff; John T Watson; Tariq A Madani
Journal:  Emerg Infect Dis       Date:  2015-11       Impact factor: 6.883

9.  The Characteristics of Middle Eastern Respiratory Syndrome Coronavirus Transmission Dynamics in South Korea.

Authors:  Yunhwan Kim; Sunmi Lee; Chaeshin Chu; Seoyun Choe; Saeme Hong; Youngseo Shin
Journal:  Osong Public Health Res Perspect       Date:  2016-01-18

10.  Superspreading SARS events, Beijing, 2003.

Authors:  Zhuang Shen; Fang Ning; Weigong Zhou; Xiong He; Changying Lin; Daniel P Chin; Zonghan Zhu; Anne Schuchat
Journal:  Emerg Infect Dis       Date:  2004-02       Impact factor: 6.883

View more
  20 in total

1.  Factors Affecting COVID-19 Transmission and Modelling of Close Contact Tracing Strategies.

Authors:  Shahram Yazdani; Majid Heydari; Zeynab Foroughi; Hadi Jabali
Journal:  Iran J Public Health       Date:  2021-10       Impact factor: 1.429

2.  Clustering and mapping the first COVID-19 outbreak in France.

Authors:  Regis Darques; Julie Trottier; Raphael Gaudin; Nassim Ait-Mouheb
Journal:  BMC Public Health       Date:  2022-07-01       Impact factor: 4.135

3.  Contacts and behaviours of university students during the COVID-19 pandemic at the start of the 2020/2021 academic year.

Authors:  Emily Nixon; Adam Trickey; Hannah Christensen; Adam Finn; Amy Thomas; Caroline Relton; Clara Montgomery; Gibran Hemani; Jane Metz; Josephine G Walker; Katy Turner; Rachel Kwiatkowska; Sarah Sauchelli; Leon Danon; Ellen Brooks-Pollock
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

4.  Drive-through Medicine for COVID-19 and Future Pandemics.

Authors:  Jessica Ngo; Shashank Ravi; Naryeong Kim; Milana Boukhman
Journal:  West J Emerg Med       Date:  2020-12-16

5.  Prevalence and fatality rates of COVID-19: What are the reasons for the wide variations worldwide?

Authors:  Jaffar A Al-Tawfiq; Roberto Leonardi; Gino Fasoli; Daniele Rigamonti
Journal:  Travel Med Infect Dis       Date:  2020-04-29       Impact factor: 6.211

6.  Mathematical models for devising the optimal SARS-CoV-2 strategy for eradication in China, South Korea, and Italy.

Authors:  Shuo Jiang; Qiuyue Li; Chaoqun Li; Shanshan Liu; Xiaomeng He; Tao Wang; Hua Li; Christopher Corpe; Xiaoyan Zhang; Jianqing Xu; Jin Wang
Journal:  J Transl Med       Date:  2020-09-05       Impact factor: 5.531

7.  Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany.

Authors:  Hendrik Streeck; Bianca Schulte; Beate M Kümmerer; Enrico Richter; Tobias Höller; Christine Fuhrmann; Eva Bartok; Ramona Dolscheid-Pommerich; Moritz Berger; Lukas Wessendorf; Monika Eschbach-Bludau; Angelika Kellings; Astrid Schwaiger; Martin Coenen; Per Hoffmann; Birgit Stoffel-Wagner; Markus M Nöthen; Anna M Eis-Hübinger; Martin Exner; Ricarda Maria Schmithausen; Matthias Schmid; Gunther Hartmann
Journal:  Nat Commun       Date:  2020-11-17       Impact factor: 14.919

8.  Fast Response to Superspreading: Uncertainty and Complexity in the Context of COVID-19.

Authors:  Lukas Zenk; Gerald Steiner; Miguel Pina E Cunha; Manfred D Laubichler; Martin Bertau; Martin J Kainz; Carlo Jäger; Eva S Schernhammer
Journal:  Int J Environ Res Public Health       Date:  2020-10-27       Impact factor: 3.390

Review 9.  A Review of Psychological Issues among Patients and Healthcare Staff during Two Major Coronavirus Disease Outbreaks in China: Contributory Factors and Management Strategies.

Authors:  Ka Ming Chow; Bernard M H Law; Marques S N Ng; Dorothy N S Chan; Winnie K W So; Cho Lee Wong; Carmen W H Chan
Journal:  Int J Environ Res Public Health       Date:  2020-09-14       Impact factor: 3.390

10.  Is Herd Immunity Against SARS-CoV-2 a Silver Lining?

Authors:  Ramachandran Vignesh; Esaki M Shankar; Vijayakumar Velu; Sadras Panchatcharam Thyagarajan
Journal:  Front Immunol       Date:  2020-09-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.